CD34 and acute myeloid leukemia: In AML, LSCs have been described as a heterogeneous and relatively rare cell population that could be isolated from the leukemic bulk population by flow cytometry based on expression of a set of specific cell surface markers, including CD34+CD38− (20, 21).